[1]
Sahu A,Pangburn MK, Covalent attachment of human complement C3 to IgG. Identification of the amino acid residue involved in ester linkage formation. The Journal of biological chemistry. 1994 Nov 18; [PubMed PMID: 7961863]
[2]
Sahu A,Pangburn MK, Tyrosine is a potential site for covalent attachment of activated complement component C3. Molecular immunology. 1995 Jul; [PubMed PMID: 7659097]
[3]
Müller-Eberhard HJ,Götze O, C3 proactivator convertase and its mode of action. The Journal of experimental medicine. 1972 Apr 1; [PubMed PMID: 4111773]
[4]
Ferreira VP,Pangburn MK,Cortés C, Complement control protein factor H: the good, the bad, and the inadequate. Molecular immunology. 2010 Aug; [PubMed PMID: 20580090]
[5]
Choteau L,Vasseur F,Lepretre F,Figeac M,Gower-Rousseau C,Dubuquoy L,Poulain D,Colombel JF,Sendid B,Jawhara S, Polymorphisms in the Mannose-Binding Lectin Gene are Associated with Defective Mannose-Binding Lectin Functional Activity in Crohn's Disease Patients. Scientific reports. 2016 Jul 12; [PubMed PMID: 27404661]
[6]
Hammad NM,El Badawy NE,Ghramh HA,Al Kady LM, Mannose-Binding Lectin: A Potential Therapeutic Candidate against {i}Candida{/i} Infection. BioMed research international. 2018; [PubMed PMID: 29854737]
[7]
Hammad NM,El Badawy NE,Nasr AM,Ghramh HA,Al Kady LM, Mannose-Binding Lectin Gene Polymorphism and Its Association with Susceptibility to Recurrent Vulvovaginal Candidiasis. BioMed research international. 2018; [PubMed PMID: 29850562]
[8]
Bíró A,Rovó Z,Papp D,Cervenak L,Varga L,Füst G,Thielens NM,Arlaud GJ,Prohászka Z, Studies on the interactions between C-reactive protein and complement proteins. Immunology. 2007 May; [PubMed PMID: 17244159]
[9]
Hakulinen J,Junnikkala S,Sorsa T,Meri S, Complement inhibitor membrane cofactor protein (MCP; CD46) is constitutively shed from cancer cell membranes in vesicles and converted by a metalloproteinase to a functionally active soluble form. European journal of immunology. 2004 Sep; [PubMed PMID: 15307194]
[10]
Kinoshita T, Congenital Defects in the Expression of the Glycosylphosphatidylinositol-Anchored Complement Regulatory Proteins CD59 and Decay-Accelerating Factor. Seminars in hematology. 2018 Jul; [PubMed PMID: 30032750]
[11]
Toomey CB,Cauvi DM,Pollard KM, The role of decay accelerating factor in environmentally induced and idiopathic systemic autoimmune disease. Autoimmune diseases. 2014; [PubMed PMID: 24592327]
[12]
Auret J,Abrahams A,Prince S,Heckmann JM, The effects of prednisone and steroid-sparing agents on decay accelerating factor (CD55) expression: implications in myasthenia gravis. Neuromuscular disorders : NMD. 2014 Jun; [PubMed PMID: 24703255]
[13]
Wei Y,Ji Y,Guo H,Zhi X,Han S,Zhang Y,Gao Y,Chang Y,Yan D,Li K,Liu DX,Sun S, CD59 association with infectious bronchitis virus particles protects against antibody-dependent complement-mediated lysis. The Journal of general virology. 2017 Nov; [PubMed PMID: 29068273]
[14]
Li H,Lin S,Yang S,Chen L,Zheng X, Diagnostic value of serum complement C3 and C4 levels in Chinese patients with systemic lupus erythematosus. Clinical rheumatology. 2015 Mar; [PubMed PMID: 25597615]
[15]
Garabet L,Gilboe IM,Mowinckel MC,Jacobsen AF,Mollnes TE,Sandset PM,Jacobsen EM, Antiphospholipid Antibodies are Associated with Low Levels of Complement C3 and C4 in Patients with Systemic Lupus Erythematosus. Scandinavian journal of immunology. 2016 Aug; [PubMed PMID: 27135178]
[16]
Birmingham DJ,Irshaid F,Nagaraja HN,Zou X,Tsao BP,Wu H,Yu CY,Hebert LA,Rovin BH, The complex nature of serum C3 and C4 as biomarkers of lupus renal flare. Lupus. 2010 Oct; [PubMed PMID: 20605879]
[17]
Ricker DM,Hebert LA,Rohde R,Sedmak DD,Lewis EJ,Clough JD, Serum C3 levels are diagnostically more sensitive and specific for systemic lupus erythematosus activity than are serum C4 levels. The Lupus Nephritis Collaborative Study Group. American journal of kidney diseases : the official journal of the National Kidney Foundation. 1991 Dec; [PubMed PMID: 1962653]
[18]
Costabile M, Measuring the 50% haemolytic complement (CH50) activity of serum. Journal of visualized experiments : JoVE. 2010 Mar 29; [PubMed PMID: 20351687]
[19]
Wilczek E,Rzepko R,Nowis D,Legat M,Golab J,Glab M,Gorlewicz A,Konopacki F,Mazurkiewicz M,Sladowski D,Gornicka B,Wasiutynski A,Wilczynski GM, The possible role of factor H in colon cancer resistance to complement attack. International journal of cancer. 2008 May 1; [PubMed PMID: 18183578]
[20]
Junnikkala S,Hakulinen J,Jarva H,Manuelian T,Bjørge L,Bützow R,Zipfel PF,Meri S, Secretion of soluble complement inhibitors factor H and factor H-like protein (FHL-1) by ovarian tumour cells. British journal of cancer. 2002 Nov 4; [PubMed PMID: 12402151]
[21]
Hallström T,Zipfel PF,Blom AM,Lauer N,Forsgren A,Riesbeck K, Haemophilus influenzae interacts with the human complement inhibitor factor H. Journal of immunology (Baltimore, Md. : 1950). 2008 Jul 1; [PubMed PMID: 18566420]
[22]
Hammerschmidt S,Agarwal V,Kunert A,Haelbich S,Skerka C,Zipfel PF, The host immune regulator factor H interacts via two contact sites with the PspC protein of Streptococcus pneumoniae and mediates adhesion to host epithelial cells. Journal of immunology (Baltimore, Md. : 1950). 2007 May 1; [PubMed PMID: 17442969]
[23]
Chung KM,Liszewski MK,Nybakken G,Davis AE,Townsend RR,Fremont DH,Atkinson JP,Diamond MS, West Nile virus nonstructural protein NS1 inhibits complement activation by binding the regulatory protein factor H. Proceedings of the National Academy of Sciences of the United States of America. 2006 Dec 12; [PubMed PMID: 17132743]
[24]
Singer L,Whitehead WT,Akama H,Katz Y,Fishelson Z,Wetsel RA, Inherited human complement C3 deficiency. An amino acid substitution in the beta-chain (ASP549 to ASN) impairs C3 secretion. The Journal of biological chemistry. 1994 Nov 11; [PubMed PMID: 7961791]
[25]
Katz Y,Singer L,Wetsel RA,Schlesinger M,Fishelson Z, Inherited complement C3 deficiency: a defect in C3 secretion. European journal of immunology. 1994 Jul; [PubMed PMID: 8026514]
[26]
Matsuyama W,Nakagawa M,Takashima H,Muranaga F,Sano Y,Osame M, Molecular analysis of hereditary deficiency of the third component of complement (C3) in two sisters. Internal medicine (Tokyo, Japan). 2001 Dec; [PubMed PMID: 11813855]
[27]
Sano Y,Nishimukai H,Kitamura H,Nagaki K,Inai S,Hamasaki Y,Maruyama I,Igata A, Hereditary deficiency of the third component of complement in two sisters with systemic lupus erythematosus-like symptoms. Arthritis and rheumatism. 1981 Oct; [PubMed PMID: 7306227]
[28]
Borzy MS,Houghton D, Mixed-pattern immune deposit glomerulonephritis in a child with inherited deficiency of the third component of complement. American journal of kidney diseases : the official journal of the National Kidney Foundation. 1985 Jan; [PubMed PMID: 3155591]
[30]
Parker CJ, Update on the diagnosis and management of paroxysmal nocturnal hemoglobinuria. Hematology. American Society of Hematology. Education Program. 2016 Dec 2; [PubMed PMID: 27913482]
[32]
Morelli C,Formica V,Pellicori S,Menghi A,Guarino MD,Perricone R,Roselli M, Chemotherapy in Patients with Hereditary Angioedema. Anticancer research. 2018 Dec; [PubMed PMID: 30504393]
[33]
Zeerleder S,Levi M, Hereditary and acquired C1-inhibitor-dependent angioedema: from pathophysiology to treatment. Annals of medicine. 2016; [PubMed PMID: 27018196]